 |
 |
||||||||
|
|||||||||
 |
|
||||||||
|
|||||||||
 |
|
||||||||
|
|||||||||
 |
|||||||||
|
|||||||||
 |
|
||||||||
|
|||||||||
 |
|
||||||||
|
|||||||||
 |
|
||||||||
|
|||||||||
 |
|
||||||||
|
|||||||||
In Brief Professor Michael Schlander is founder and chairman of the independent Institute for Innovation & Valuation in Health Care (InnoValHC), a non-profit, non-partisan scientific organization dedicated to research related to the utilization, effectiveness, efficiency, and quality of health care, with particular emphasis on novel approaches of service provision. He has taught, and continues to teach, health economics and innovation management at the University of Heidelberg, Mannheim Medical Faculty (since 2007; previously at the University of Duisburg-Essen, Faculty of Medicine, 2005-2008, and at the University of Witten/Herdecke, Faculty of Medicine, 1996-2005), and at the University of Applied Economic Sciences Ludwigshafen, Germany (since 2002). Prior to his full-time university appointment in 2002, he spent fifteen years in executive positions with international research-based pharmaceutical companies in Germany, Belgium, and the United States. Before that, he had spent six years in experimental brain research and clinical neurology at German universities.
In Detail Founder and Chairman of INNOVALHC
Health Economist at the University of Heidelberg, Germany, Mannheim Medical Faculty, Department of Public Health, Social and Preventive Medicine (since 2006) Member of Scientific Steering Committee, Postgraduate Program in Pharmaceutical Medicine, responsible for courses in health economics and innovation management at the University of Duisburg-Essen, Germany (2005-2008); before that, founding member of Scientific Steering Committee, Postgraduate Program in Pharmaceutical Medicine, and Member of Faculty of Medicine, University of Witten/Herdecke, Germany (1996-2005) Professor of Business Administration and (Technology, Innovation, Life Sciences & Health Care) Management (since September 2002; position offered in January 2002, accepted: February 2002) at the University of Applied Economic Sciences (Hochschule fuer Wirtschaft), Ludwigshafen am Rhein, Germany; scientific focus on health economics and innovation management
Academic Roles Institute for
Innovation & Valuation in Health Care: University
of Heidelberg, Mannheim
Institute for Public Health, Visiting Scientist and Privatdozent
(PD) for Health Economics University of Applied
Economic Sciences Ludwigshafen, Professor for Business Administration
and Management
Academic Background "Habilitation" (venia
legendi, Ph.D. equivalent) Diploma in Health Economics, Master of Business Administration
(M.B.A.), Dr. med. (M.D.), Licensed as a physician in
Germany,
Major Areas of Scientific Interest Please refer to “Research”.
Publications Predominantly in the fields of experimental brain research, innovation management, and health economics. More than 250 scientific contributions to international meetings and journals including (in alphabetical order): American Journal of Psychiatry, Anatomy & Embryology, Annals of Haematology, Applied Clinical Trials, Brain Research, Cell and Tissue Research, Child and Adolescent Psychiatry and Mental Health (CAPMH), Drug Information Journal, European Child and Adolescent Psychiatry (ECAP), European Journal of Clinical Chemistry & Clinical Biochemistry, Gastroenterology, Gut, Health Affairs, Health Services Research, International Journal of Clinical Pharma-cology and Therapeutics, Journal of Clinical Anesthesia, Journal of Medical Ethics, Neuroscience, Neuroscience Letters, Pharmaceutical Executive, Progress of Clinical & Biological Research, Value in Health, as well as a number of German periodicals, such as Deutsches Ärzteblatt, Gesellschafts-politische Kommentare, Gesundheitsökonomie & Qualitätsmanagement, Kassenarzt, Medizinische Klinik, Münchner Medizinische Wochenschrift (MMW) / Fortschritte der Medizin, PharmInd – Die pharmazeutische Industrie, and psychoneuro. A complete list of publications will be provided on request. For further information, please also refer
Member of Scientific Associations Including the following: International Health Economics Association (iHEA), Association of German speaking economists (Verein für Socialpolitik), Product Development & Management Association (pdma), Drug Information Association (DIA), International Society for Pharmaoeconomics and Outcomes Research (ISPOR), German Society for Pharmaceutical Medicine (Deutsche Gesellschaft für Pharmazeutische Medizin, DGPharMed), Association of German Medical Writers (Vereinigung der Deutschen Medizinischen Fach-und Standespresse im VDJM), Frankfurt Medical Society (Frankfurter Medizinische Gesellschaft, FMG and Gesundheitsnetz Rhein-Neckar-Dreieck (GN-RND).
Professional Background Professional experience gathered in Germany, Belgium, and the United States of America: Professor of Business Administration and Management University of Applied Economic Sciences (Hochschule für Wirtschaft)
Ludwigshafen am Rhein Managing Director Pharmaceutical / Medical Device Industry Strategic and Tactical Marketing Pharmaceutical Industry Clinical Research and Development Pharmaceutical Industry Experimental Brain Research and Clinical Neurology (April 1, 1982 - August 31, 1987)
|
